Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 5/20 | 0.44 |
| ▸ | DNPEP | Q9ULA0 | 4/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 4/20 | 0.43 |
| ▸ | LAP3 | P28838 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NMT2 | O60551 | 1/20 | 0.36 |
| ▸ | NMT1 | P30419 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25682469 | 0.85 | L3MBTL1 (0.34) | KMT2ATHRBL3MBTL1KDM4E | |
| SCHEMBL19302564 | 0.82 | TERT (0.31) | — | |
| SCHEMBL20887626 | 0.81 | PKM (0.33) | MAPTSMN1; SMN2LMNA | |
| SCHEMBL18165057 | 0.79 | PAOX (0.39) | — | |
| SCHEMBL19295814 | 0.79 | AKT1 (0.33) | — | |
| SCHEMBL17721386 | 0.78 | P2RX4 (0.34) | MEN1KMT2AMAPTTHRB | |
| SCHEMBL17254417 | 0.78 | DNMT1 (0.32) | — | |
| SCHEMBL25679995 | 0.77 | MTNR1A (0.32) | SMN1; SMN2 | |
| SCHEMBL18161922 | 0.76 | HDAC3 (0.35) | — | |
| SCHEMBL28646996 | 0.76 | TSHR (0.35) | THRBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11857638-B2 | Quinone-containing conjugates | PROMEGA CORPORATION (US) | 2024-01-02 | — | — | US | disclosed |
| US-20200030456-A1 | QUINONE-CONTAINING CONJUGATES | PROMEGA CORPORATION | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200030456-A1 | QUINONE-CONTAINING CONJUGATES | NQO1, NQO2, SQOR | ANPEP 2279/4885DNPEP 158/4885RNPEP 2687/4885 |
| US-11857638-B2 | Quinone-containing conjugates | NQO1, NQO2, SQOR | ANPEP 2279/4885DNPEP 158/4885RNPEP 2687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.